Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and Groton to Co-Market HPLC-Integrated Tool in North America

NEW YORK (GenomeWeb News) — Agilent Technologies and Groton Biosystems will co-market Groton’s Process Analytic Technology to pharmaceutical companies in North America, the companies said today.
 
PAT integrates Agilent’s 1200 series high-performance liquid chromatography instrument with Groton’s online sampling products and services. The tool is designed to help drug makers design, analyze, and control how raw and in-process materials are manufactured, the companies said. 
 
As part of the deal the firms will market the tools at trade shows, customer events, and product presentations, the companies said. 
 
The companies also said they expect in the “near future” to expand the agreement to Europe and Asia.
 
Financial terms of the agreement were not released.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.